Richmond Pharmacology LTD

Richmond Pharmacology Ltd was established in 2001 and has fast become one of the largest Early Phase full-service CROs in the UK. To date, we have performed over 270 clinical studies which have covered a huge range of early phase studies in patients and healthy subjects. Approximately 10% of all phase one studies that Richmond carry out are conducted in the UK and 1 in every 100 of our studies are carried out worldwide.

Here are some things you should know about Richmond Pharmacology Ltd:

• We are an established clinical pharmacology unit that has been under the same senior management for over a decade. This has resulted in Richmond having a streamlined process and uniformity for all our studies.
• Our Principal Investigators have over 20 years practical experience in early phase research, adding value to our Sponsors through our experience.
• We have a longstanding affiliation with a expert Scientific Advisory Board and a group of clinicians in various therapeutic areas. These experts often work with in our trials offering their expertise, flexibility and resources.
• Our sophisticated methods ensure we consistently deliver on project milestones that are set by our sponsors’ time and cost requirements initially set.
• Our innovative approach to Phase I ethnic comparison can accelerate global development programs, saving Sponsors time and money in the long-term.
• Richmond offer cost-effective solutions compared to larger CROs. This is due to the size of our operations and the personal involvement of our experienced Principal Investigators.
• We are one of only 15 MHRA (Medicines and Healthcare Products Regulatory) accredited clinical pharmacology units in the UK.
• Our presence within acute teaching hospitals in London ensures that we are working in an optimum safety environment. Working in a hospital means that we have access to 24-hour emergency and acute medical services.
• We have access to a high number of healthy and patient clinical trial volunteers. Our patients are of various ethnicities, including Japanese and other Asian nationalities.
• As we are located in London, we have access to a high population density and diversity, This allows Richmond to directly translate any data gained into other regions.